Dapatorq-V100 Tablets

Dapatorq-V100 Tablets contains Dapagliflozin is a highly potent, selective and reversible inhibitor of SGLT2 and Vildagliptin, a member of the islet enhancer class, is a potent and selective DPP-4 inhibitor.

Dosage Form

Tablet

Route of Administration

Oral

Composition

Dapagliflozin Propanediol Monohydrate Eq. to Dapagliflozin U.S.P. 10 mg
Vildagliptin (As sustained release) I.P. 100 mg
Excipients q.s.

Indications

Dapatorq-V100 is indicated for the treatment of patients with type II diabetes mellitus when diet, exercise, and a single agent do not result in adequate glycemic control.

Storage

Store protected from light & moisture, at a temperature not exceeding 25°C.

Precautions

Use with caution in patients with kidney impairment, dehydration, or a history of recurrent urinary tract or genital infections. Monitor blood glucose and renal function regularly during treatment. Maintain adequate hydration and watch for signs of hypoglycemia, especially when used with other antidiabetic medicines. Inform your healthcare provider about all medications being taken, including diuretics, warfarin, digoxin, ACE inhibitors, rifampicin, and mefenamic acid.

Presentation

10x10 Tablets

Download product information as a PDF

Download PDF

GLOBAL HORIZONS

Your Efforts Extended Through a Partnership That's Better Together

Become a Dealer